Ben R. Taylor, Chief Financial Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 42,766 shares at $4.18 ($179K) on 2025-12-29, disclosed to the SEC on 2025-12-30.
Scheduled sale ($179k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.18 | 21,383 | $89K | 50.0% |
| 2 | $4.18 | 21,383 | $89K | 50.0% |
| Total | $4.18 avg | 42,766 | $179K | 100% |
| Filing → |
| TYME | BUY | 2019-06-17 | $10K | — | Filing → |